Expression of the PI3K/AKT/mTOR pathway as a prognostic factor in patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy.

Autor: Cierniak, S.¹, Koktysz, R.¹, Jesiotr, M.¹, Gąsowska-Bodnar, A.², Bodnar, L.³ lubo@esculap.pl

Publikováno v: European Journal of Gynaecological Oncology. 2019, Vol. 40 Issue 5, p744-751. 8p.

The impact of implantation site on procedure success in patients with unresolved facial palsy treated with upper-eyelid gold weight loading.

Autor: Nowak-Gospodarowicz I; Department of Ophthalmology, Military Institute of Medicine, 128 Szaserow St., 04-141, Warsaw, Poland. inowak-gospodarowicz@wim.mil.pl., Koktysz R; Department of Pathology, Military Institute of Medicine, 128 Szaserow St., 04-141, Warsaw, Poland., Rękas M; Department of Ophthalmology, Military Institute of Medicine, 128 Szaserow St., 04-141, Warsaw, Poland.

Publikováno v: Scientific reports [Sci Rep] 2022 Jul 13; Vol. 12 (1), pp. 11869. Date of Electronic Publication: 2022 Jul 13.

Equipping computational pathology systems with artifact processing pipelines: a showcase for computation and performance trade-offs.

Autor: Kanwal, Neel¹ (AUTHOR) neel.kanwal@uis.no, Khoraminia, Farbod² (AUTHOR), Kiraz, Umay^3,4 (AUTHOR), Mosquera-Zamudio, Andrés⁵ (AUTHOR), Monteagudo, Carlos⁵ (AUTHOR), Janssen, Emiel A. M.^3,4 (AUTHOR), Zuiverloon, Tahlita C. M.² (AUTHOR), Rong, Chunming¹ (AUTHOR), Engan, Kjersti¹ (AUTHOR) kjersti.engan@uis.no

Publikováno v: BMC Medical Informatics & Decision Making. 10/7/2024, Vol. 24 Issue 1, p1-25. 25p.

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

Autor: Czystowska-Kuzmicz M; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Sosnowska A; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland.; School of Molecular Medicine, Medical University of Warsaw, Warsaw, 02-091, Poland., Nowis D; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland.; Laboratory of Experimental Medicine, Center of New Technologies, University of Warsaw, Warsaw, 02-097, Poland.; Genomic Medicine, Medical University of Warsaw, Warsaw, 02-097, Poland., Ramji K; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Szajnik M; Holy Family Obstetrics and Gynecology Hospital, Warsaw, 02-544, Poland.; Institute of Mother and Child, Obstetrics and Gynaecology Clinic, Warsaw, 01-211, Poland., Chlebowska-Tuz J; Laboratory of Experimental Medicine, Center of New Technologies, University of Warsaw, Warsaw, 02-097, Poland., Wolinska E; Department of Pathology, Medical University of Warsaw, Warsaw, 02-142, Poland., Gaj P; Laboratory of Human Cancer Genetics, Center of New Technologies, University of Warsaw, Warsaw, 02-097, Poland., Grazul M; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Pilch Z; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Zerrouqi A; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Graczyk-Jarzynka A; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Soroczynska K; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Cierniak S; Department of Gynecology and Gynecologic Oncology, Military Institute of Medicine, Warsaw, 04-141, Poland., Koktysz R; Department of Gynecology and Gynecologic Oncology, Military Institute of Medicine, Warsaw, 04-141, Poland., Elishaev E; Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, 15123, PA, USA., Gruca S; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland., Stefanowicz A; Department of Gynecology and Obstetrics, 'Praski' Hospital, Warsaw, 03-401, Poland., Blaszczyk R; OncoArendi Therapeutics, Warsaw, 02-089, Poland., Borek B; OncoArendi Therapeutics, Warsaw, 02-089, Poland., Gzik A; OncoArendi Therapeutics, Warsaw, 02-089, Poland., Whiteside T; Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, 15123, PA, USA.; Department of Immunology and Otorhinolaryngology, UPMC Hillman Cancer Center, Pittsburgh, 15213, PA, USA., Golab J; Department of Immunology, Medical University of Warsaw, Warsaw, 02-097, Poland. jakub.golab@wum.edu.pl.; Centre of Preclinical Research, Medical University of Warsaw, Warsaw, 02-091, Poland. jakub.golab@wum.edu.pl.

Publikováno v: Nature communications [Nat Commun] 2019 Jul 05; Vol. 10 (1), pp. 3000. Date of Electronic Publication: 2019 Jul 05.

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines.

Autor: Bodnar L; Department of Oncology, Military Institute of Medicine, Warsaw, Poland. Electronic address: lubo@esculap.pl., Stec R; Department of Oncology, Military Institute of Medicine, Warsaw, Poland., Cierniak S; Department of Pathology, Military Institute of Medicine, Warsaw, Poland., Synowiec A; Department of Oncology, Military Institute of Medicine, Warsaw, Poland., Wcisło G; Department of Pathology, Military Institute of Medicine, Warsaw, Poland., Jesiotr M; Department of Pathology, Military Institute of Medicine, Warsaw, Poland., Koktysz R; Department of Pathology, Military Institute of Medicine, Warsaw, Poland., Chrom P; Department of Oncology, Military Institute of Medicine, Warsaw, Poland., Szczylik C; Department of Oncology, Military Institute of Medicine, Warsaw, Poland.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2018 Aug; Vol. 16 (4), pp. 257-265. Date of Electronic Publication: 2018 Feb 02.